Interaction between Notch signaling pathway and bioactive compounds and its intervention on cancer

Rong-Zu Nie1,2, Hang Wang1,2, Shuang-Shuang Wang1,2

  • 1College of Food and Bioengineering, Zhengzhou University of Light Industry, Zhengzhou, China.

Frontiers in Nutrition
|October 9, 2025
PubMed

Insights

Natural compounds can modulate the Notch signaling pathway, offering new cancer prevention and therapy strategies. These bioactive compounds show potential for targeted cancer treatments with low toxicity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • The Notch signaling pathway plays a crucial, context-dependent role in cancer development, acting as both a promoter and inhibitor.
  • Understanding the complex mechanisms of Notch signaling in carcinogenesis is essential for developing effective cancer therapies.
  • The dual role of Notch signaling necessitates nuanced therapeutic strategies tailored to specific cancer types and microenvironments.

Purpose of the Study:

  • To review the structural and functional mechanisms of Notch signaling in cancer.
  • To examine the influence of natural bioactive compounds on Notch signaling activity.
  • To explore the potential of these compounds for cancer prevention and targeted therapy.

Main Methods:

  • Literature review of studies on Notch signaling in cancer.
  • Analysis of research on natural bioactive compounds (flavonoids, polyphenols, terpenoids) as Notch modulators.
  • Examination of specific compounds like resveratrol, curcumin, and EGCG and their effects on cancer cell proliferation and inflammation.

Main Results:

  • Natural compounds, including flavonoids, polyphenols, and terpenoids, demonstrate potential in modulating Notch signaling.
  • Compounds such as resveratrol, curcumin, and epigallocatechin gallate (EGCG) can inhibit key Notch signaling nodes.
  • These compounds exhibit low toxicity and multi-target effects, reducing cancer cell proliferation and inflammation.

Conclusions:

  • Natural bioactive compounds offer promising avenues for modulating Notch signaling in cancer therapy.
  • Targeting Notch signaling presents challenges due to its complexity and cancer-specific variability.
  • Future research should focus on tissue-specific effects, compound optimization, and integrated clinical studies for precision therapies.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K